Bioline Rx reported $62.57M in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Arca Biopharma USD 37K 0 Mar/2025
Bio Path USD 8K 2K Mar/2025
Bioline Rx USD 62.57M 24.47M Mar/2025
Capricor Therapeutics USD 46K 0 Mar/2025